{"id":"NCT00130793","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)","officialTitle":"A Double-Blind, Randomized, Controlled, Multicenter Study to Evaluate the Safety, Tolerability and Immunogenicity of a Refrigerator-Stable Formulation of Zoster Vaccine Live (Oka/Merck)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-08","primaryCompletion":"2005-11","completion":"2005-11","firstPosted":"2005-08-16","resultsPosted":"2009-07-03","lastUpdate":"2015-01-26"},"enrollment":368,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Herpes Zoster"],"interventions":[{"type":"BIOLOGICAL","name":"Comparator: zoster vaccine live (Oka/Merck) refrigerated formulation","otherNames":[]},{"type":"BIOLOGICAL","name":"Comparator: zoster vaccine live (Oka/Merck) frozen formulation","otherNames":[]}],"arms":[{"label":"zoster vaccine live (Oka/Merck) refrigerated formulation","type":"EXPERIMENTAL"},{"label":"zoster vaccine live (Oka/Merck) frozen formulation","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine whether the refrigerator-stable formulation of an investigational vaccine has a comparable immune response (the body's ability to protect against disease) and safety profile to that of the freezer-stable formulation of the vaccine.","primaryOutcome":{"measure":"Geometric Mean Titer (GMT) of Varicella-zoster Virus (VZV) Antibody Responses at 4 Weeks Postvaccination","timeFrame":"4 weeks","effectByArm":[{"arm":"ZOSTAVAX™ With PGSU","deltaMin":717.5,"sd":null},{"arm":"ZOSTAVAX™ With PGS","deltaMin":844.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":1,"exclusionCount":3},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["18077611"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":180},"commonTop":["Injection site pain","Injection site erythema","Injection site swelling","Injection site pruritus"]}}